JSR Corp
TSE:4185
JSR Corp
TSE:4185
Price:
999 999.9999
JPY
Market Cap:
903.4B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
JSR Corp
999999.9999
0.0000 (0%)
| 52 Week Range |
3 891.2679
999 999.9999
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
JSR Corp
Balance Sheet
Balance Sheet Decomposition
JSR Corp
JSR Corp
| Current Assets | 309.9B |
| Cash & Short-Term Investments | 101.4B |
| Receivables | 87.9B |
| Other Current Assets | 120.7B |
| Non-Current Assets | 461.4B |
| Long-Term Investments | 52.5B |
| PP&E | 174.9B |
| Intangibles | 202.6B |
| Other Non-Current Assets | 31.4B |
| Current Liabilities | 215.8B |
| Accounts Payable | 79.7B |
| Other Current Liabilities | 136.1B |
| Non-Current Liabilities | 179.8B |
| Long-Term Debt | 81.5B |
| Other Non-Current Liabilities | 98.3B |
Balance Sheet
JSR Corp
JSR Corp
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
47 984
|
52 081
|
97 416
|
124 956
|
70 785
|
61 931
|
85 377
|
45 567
|
72 640
|
100 645
|
|
| Cash Equivalents |
47 984
|
52 081
|
97 416
|
124 956
|
70 785
|
61 931
|
85 377
|
45 567
|
72 640
|
100 645
|
|
| Short-Term Investments |
67 997
|
60 010
|
44 970
|
13 776
|
5 002
|
4 064
|
1 933
|
1 289
|
2 657
|
717
|
|
| Total Receivables |
83 122
|
77 878
|
116 587
|
128 764
|
142 496
|
117 912
|
131 612
|
87 617
|
78 999
|
87 897
|
|
| Accounts Receivables |
83 122
|
77 878
|
88 148
|
98 793
|
116 956
|
97 759
|
108 615
|
68 674
|
78 999
|
87 897
|
|
| Other Receivables |
0
|
0
|
28 439
|
29 971
|
25 540
|
20 153
|
22 997
|
18 943
|
0
|
0
|
|
| Inventory |
79 320
|
77 458
|
81 918
|
87 567
|
117 046
|
112 840
|
104 862
|
104 934
|
118 494
|
103 910
|
|
| Other Current Assets |
40 973
|
33 105
|
3 237
|
2 845
|
3 654
|
6 728
|
5 495
|
197 595
|
26 718
|
16 749
|
|
| Total Current Assets |
319 396
|
300 532
|
344 128
|
357 908
|
338 983
|
303 475
|
329 279
|
437 002
|
299 507
|
309 918
|
|
| PP&E Net |
115 913
|
112 693
|
131 748
|
159 834
|
183 457
|
215 664
|
170 428
|
159 539
|
169 617
|
174 891
|
|
| PP&E Gross |
0
|
0
|
131 748
|
159 834
|
183 457
|
215 664
|
170 428
|
159 539
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
374 751
|
383 935
|
436 648
|
451 033
|
545 013
|
251 940
|
0
|
0
|
|
| Intangible Assets |
7 819
|
6 875
|
9 190
|
10 403
|
14 205
|
15 891
|
15 014
|
24 571
|
47 664
|
49 509
|
|
| Goodwill |
6 479
|
9 788
|
9 331
|
19 389
|
59 066
|
58 283
|
58 633
|
117 640
|
135 735
|
153 107
|
|
| Note Receivable |
0
|
5 894
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
78 456
|
73 660
|
68 241
|
89 747
|
83 164
|
70 041
|
70 766
|
34 392
|
35 636
|
52 533
|
|
| Other Long-Term Assets |
6 529
|
6 917
|
15 846
|
10 418
|
12 560
|
14 359
|
28 653
|
36 227
|
29 352
|
31 397
|
|
| Other Assets |
6 479
|
9 788
|
9 331
|
19 389
|
59 066
|
58 283
|
58 633
|
117 640
|
135 735
|
153 107
|
|
| Total Assets |
534 592
N/A
|
516 359
-3%
|
578 484
+12%
|
647 699
+12%
|
691 435
+7%
|
677 713
-2%
|
672 773
-1%
|
809 371
+20%
|
717 511
-11%
|
771 355
+8%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
72 441
|
53 836
|
75 025
|
82 941
|
117 373
|
92 335
|
100 272
|
63 143
|
79 872
|
79 714
|
|
| Accrued Liabilities |
0
|
0
|
5 026
|
5 274
|
6 105
|
6 048
|
6 273
|
4 270
|
0
|
0
|
|
| Short-Term Debt |
16 107
|
14 345
|
15 496
|
18 901
|
21 695
|
23 559
|
22 333
|
60 634
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2 532
|
6 495
|
8 244
|
7 046
|
11 824
|
6 484
|
18 869
|
11 520
|
62 510
|
97 605
|
|
| Other Current Liabilities |
35 247
|
34 646
|
35 329
|
39 857
|
15 458
|
19 972
|
21 063
|
148 698
|
39 580
|
38 486
|
|
| Total Current Liabilities |
126 327
|
109 322
|
139 120
|
154 019
|
172 455
|
148 398
|
168 810
|
288 265
|
181 962
|
215 805
|
|
| Long-Term Debt |
20 387
|
22 249
|
38 381
|
53 456
|
50 777
|
52 684
|
100 449
|
64 968
|
95 683
|
81 465
|
|
| Deferred Income Tax |
6 700
|
0
|
6 432
|
9 955
|
7 565
|
3 139
|
3 077
|
5 133
|
7 162
|
11 210
|
|
| Minority Interest |
5 518
|
8 278
|
14 475
|
18 116
|
38 361
|
40 619
|
36 741
|
38 728
|
25 409
|
26 650
|
|
| Other Liabilities |
16 505
|
22 435
|
18 187
|
18 654
|
20 278
|
36 080
|
29 701
|
36 266
|
51 769
|
60 431
|
|
| Total Liabilities |
175 437
N/A
|
162 284
-7%
|
216 595
+33%
|
254 200
+17%
|
289 436
+14%
|
280 920
-3%
|
338 778
+21%
|
433 360
+28%
|
361 985
-16%
|
395 561
+9%
|
|
| Equity | |||||||||||
| Common Stock |
23 320
|
23 320
|
23 320
|
23 370
|
23 370
|
23 370
|
23 370
|
23 370
|
23 370
|
23 370
|
|
| Retained Earnings |
292 003
|
282 807
|
309 517
|
331 913
|
351 476
|
369 102
|
302 916
|
333 335
|
288 919
|
276 992
|
|
| Additional Paid In Capital |
25 179
|
25 179
|
18 441
|
18 502
|
18 436
|
18 242
|
11 562
|
11 799
|
6 637
|
6 748
|
|
| Unrealized Security Profit/Loss |
19 257
|
15 231
|
17 213
|
25 064
|
19 508
|
10 849
|
15 096
|
8 713
|
0
|
0
|
|
| Treasury Stock |
15 329
|
956
|
5 396
|
5 358
|
10 042
|
19 547
|
19 202
|
18 874
|
2 109
|
1 961
|
|
| Other Equity |
14 725
|
8 494
|
1 206
|
8
|
749
|
5 223
|
253
|
17 668
|
38 709
|
70 645
|
|
| Total Equity |
359 155
N/A
|
354 075
-1%
|
361 889
+2%
|
393 499
+9%
|
401 999
+2%
|
396 793
-1%
|
333 995
-16%
|
376 011
+13%
|
355 526
-5%
|
375 794
+6%
|
|
| Total Liabilities & Equity |
534 592
N/A
|
516 359
-3%
|
578 484
+12%
|
647 699
+12%
|
691 435
+7%
|
677 713
-2%
|
672 773
-1%
|
809 371
+20%
|
717 511
-11%
|
771 355
+8%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
230
|
226
|
223
|
223
|
220
|
215
|
215
|
215
|
208
|
208
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
